Abatacept in Immune Checkpoint Inhibitor Myocarditis — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(31 sites)
United States
Cedars-Sinai Medical Center, Los Angeles, California University of California Los Angeles, Los Angeles, California MedStar Health Research Institute, Georgetown University, Washington D.C., District of Columbia Moffitt Cancer Center, Tampa, Florida University of Chicago, Chicago, Illinois Franciscan Health, Indianapolis, Indiana University of Kansas Medical Center, Kansas City, Kansas University of Kentucky, Lexington, Kentucky Maine Health, Portland, Maine Johns Hopkins, Baltimore, Maryland Massachusetts General Hospital, Boston, Massachusetts Beth Israel Deaconess Medical Center, Boston, Massachusetts Boston Medical Center, Boston, Massachusetts Brigham and Women's Hospital, Boston, Massachusetts University of Michigan, Ann Arbor, Michigan Mayo Clinic, Rochester, Minnesota Robert Wood Johnson University Hospital, New Brunswick, New Jersey Columbia University Irving Medical Center, New York, New York Memorial Sloan Kettering Cancer Center, New York, New York University of North Carolina Chapel Hill, Chapel Hill, North Carolina Cleveland Clinic, Cleveland, Ohio Lehigh Valley Health Network, Bethlehem, Pennsylvania University of Pennsylvania, Philadelphia, Pennsylvania Allegheny-Singer Research Institution, Pittsburgh, Pennsylvania University of Texas Southwestern, Dallas, Texas MD Anderson Cancer Center, Houston, Texas University of Utah, Salt Lake City, Utah University of West Virginia, Morgantown, West Virginia Aurora St Luke's Medical Center, Milwaukee, Wisconsin Canada
University of British Colombia, Vancouver, British Colombia McMaster University, Hamilton, Ontario Last updated September 2025